Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barchiesi

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
The West Indian Medical Journal|April 24, 2014
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abacavir: a case reportO Cirioni, L E Weimer, V Fragola, et al.
Infection|May 25, 2013
Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individualsE Orsetti, S Staffolani, R Gesuita, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDSF Barchiesi, R J Hollis, D A McGough, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis modelF Barchiesi, L K Najvar, M F Luther, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumanniiA Giacometti, O Cirioni, M S Del Prete, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida sppM Del Poeta, A S Bixel, F Barchiesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2006
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospitalA Bedini, C Venturelli, C Mussini, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogensF Barchiesi, D Arzeni, A W Fothergill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresisF Barchiesi, R J Hollis, M Del Poeta, et al.
Archives of Oral Biology|February 13, 2002
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolatesGiuseppi Pizzo, F Barchiesi, L Falconi Di Francesco, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
The West Indian Medical Journal|April 24, 2014
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abacavir: a case reportO Cirioni, L E Weimer, V Fragola, et al.
Infection|May 25, 2013
Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individualsE Orsetti, S Staffolani, R Gesuita, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDSF Barchiesi, R J Hollis, D A McGough, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis modelF Barchiesi, L K Najvar, M F Luther, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumanniiA Giacometti, O Cirioni, M S Del Prete, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida sppM Del Poeta, A S Bixel, F Barchiesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2006
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospitalA Bedini, C Venturelli, C Mussini, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogensF Barchiesi, D Arzeni, A W Fothergill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresisF Barchiesi, R J Hollis, M Del Poeta, et al.
Archives of Oral Biology|February 13, 2002
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolatesGiuseppi Pizzo, F Barchiesi, L Falconi Di Francesco, et al.
Pageof 9